These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 4659049

  • 21. Lymphocyte-mediated immune responses in neoplasia.
    Pilch YH, Golub SH.
    Am J Clin Pathol; 1974 Aug; 62(2):184-211. PubMed ID: 4602086
    [No Abstract] [Full Text] [Related]

  • 22. Tumor-specific antigens: detection by local transfer of delayed skin hypersensitivity.
    Kronman BS, Rapp HJ, Borsos T.
    J Natl Cancer Inst; 1969 Oct; 43(4):869-75. PubMed ID: 4310097
    [No Abstract] [Full Text] [Related]

  • 23. Role of activated macrophages in nonspecific resistance to neoplasia.
    Hibbs JB.
    J Reticuloendothel Soc; 1976 Sep; 20(3):223-31. PubMed ID: 789879
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The gordian knot of tumour immunology.
    Amlot P.
    Guys Hosp Rep; 1974 Sep; 123(1):43-51. PubMed ID: 4549511
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Cellular immunity in mouse plasmocytomas].
    Lespinats G, Poupon MF.
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):755-65. PubMed ID: 5050876
    [No Abstract] [Full Text] [Related]

  • 29. Effect of anti-alpha1-fetoprotein on alpha1-fetoprotein-producing rat tumors in vivo and in vitro.
    Sell S, Sheppard HW, Nickel R, Stillman D, Michaelsen M.
    Cancer Res; 1976 Feb; 36(2 Pt 1):476-80. PubMed ID: 56992
    [Abstract] [Full Text] [Related]

  • 30. [Immune reaction of autochthonous tumor--analysis of cellular immunity in rejection of methylcholanthrene-induced autochthonous tumor].
    Kikuchi K, Kikuchi Y.
    Saishin Igaku; 1971 Nov; 26(11):2170-9. PubMed ID: 5141954
    [No Abstract] [Full Text] [Related]

  • 31. [Current achievements in clinical oncoimmunology].
    Gorodilova VV.
    Sov Med; 1977 Oct; (10):110-5. PubMed ID: 337523
    [No Abstract] [Full Text] [Related]

  • 32. Abrogation of tumor rejection by trypan blue.
    Kreider JW, Bartlett GL, DeFreitas E.
    Cancer Res; 1978 Apr; 38(4):1036-40. PubMed ID: 205342
    [Abstract] [Full Text] [Related]

  • 33. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA, Prehn RT.
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The effect of tumor size on concomitant tumor immunity.
    Deckers PJ, Davis RC, Parker GA, Mannick JA.
    Cancer Res; 1973 Jan; 33(1):33-9. PubMed ID: 4682321
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin.
    Zbar B, Bernstein ID, Rapp HJ.
    J Natl Cancer Inst; 1971 Apr; 46(4):831-9. PubMed ID: 4324814
    [No Abstract] [Full Text] [Related]

  • 38. [Factors of bodily resistance and metastasis].
    Maĭskiĭ IN, Lomakin MS.
    Usp Sovrem Biol; 1976 Apr; 82(4):63-76. PubMed ID: 790816
    [No Abstract] [Full Text] [Related]

  • 39. Embryonic antigens in tumor immunity.
    Della Porta G.
    Johns Hopkins Med J Suppl; 1974 Apr; 3():279-87. PubMed ID: 4138923
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.